QDEL, US2197981051

QuidelOrtho stock gained 12.72 percent as debt terms reset

Published on 10/06/2026 at 13:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

QuidelOrtho stock posted USD 630.9 million in second-quarter revenue, up 2.8 percent year over year. Its 2026 adjusted EPS guidance is USD 0.65-0.90.

QDEL, US2197981051, Illustration mit AI erstellt.

QuidelOrtho stock (ISIN US2197981051) gained 12.72 percent to USD 12.14 on Nasdaq on October 5, 2026, at 4:00 p.m. ET. The move put the diagnostic-testing company 65.9 percent below its 52-week high of USD 35.58, while its market capitalization stood at USD 827.8 million.

Credit terms reset through 2029

According to SEC.gov in a filing dated September 23, 2026, QuidelOrtho amended its existing credit agreement with Bank of America and other lenders.

The financing covers USD 1.15 billion in Term Loan A, USD 100.0 million in delayed-draw Term Loan A, USD 1.45 billion in Term Loan B and a USD 700.0 million revolving facility. The amendment resets financial covenants through the fiscal quarter ending September 30, 2029, giving the company more time under revised leverage and interest-coverage thresholds.

Revenue grew while losses stayed high

QuidelOrtho reported USD 630.9 million in second-quarter 2026 revenue, an increase of 2.8 percent from the year-earlier quarter, according to StockTitan. Labs revenue grew 4 percent and Point of Care revenue increased 16 percent, but China revenue declined 18.7 percent.

The quarter also produced a GAAP net loss of USD 92.9 million, or USD 1.36 per diluted share. Adjusted EBITDA reached USD 129.3 million, equal to a 20.5 percent margin, while full-year 2026 guidance called for USD 2.52 billion to USD 2.60 billion in revenue and USD 0.65 to USD 0.90 in adjusted EPS.

Analyst target remains above the stock

MarketBeat reports a Reduce consensus for QuidelOrtho based on six analyst ratings, with three Holds and three Sells. The average price target is USD 13.62, which lies 12.2 percent above the October 5 price of USD 12.14.

The valuation debate therefore sits between operating improvement and financial pressure. Revenue growth in the latest quarter was positive, but the GAAP loss and the amended debt covenants keep leverage and cash generation central to the stock narrative.

QDEL stock stays below its yearly high

QuidelOrtho was last at USD 12.14 on Nasdaq on October 5, 2026, at 4:00 p.m. ET, with volume of 2,692,910 shares. The 52-week range was USD 9.92 to USD 35.58, leaving the stock 65.9 percent below its high.